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Abstract
Background: Cohort studies often report findings on children with Attention Deficit Hyperactivity Disorder (ADHD)
but may be biased by self-selection. The representativeness of cohort studies needs to be investigated to determine
whether their findings can be generalised to the general child population. The aim of the present study was to
examine the representativeness of child ADHD in the Norwegian Mother and Child Cohort Study (MoBa).
Methods: The study population was children born between January 1, 2000 and December 31, 2008 registered with
hyperkinetic disorders (hereafter ADHD) in the Norwegian Patient Registry during the years 2008–2013, and two
groups of children with ADHD were identified in: 1. MoBa and 2. The general child population. We used the multiaxial
International Classification of Diseases (ICD-10) and compared the proportions of comorbid disorders (axes I–III),
abnormal psychosocial situations (axis V) and child global functioning (axis VI) between these two groups. We
also compared the relative differences in the multiaxial classifications for boys and girls and for children with/without
axis I comorbidity, respectively in these two groups of children with ADHD.
Results: A total of 11 119 children were registered with ADHD, with significantly fewer in MoBa (1.45%) than the
general child population (2.11%), p < 0.0001. The proportions of comorbid axis I, II, and III disorders were low,
with no significant group differences. Compared with the general child population with ADHD, children with
ADHD in MoBa were registered with fewer abnormal psychosocial situations (axis V: t = 7.63, p < .0001; d = -.18)
and better child global functioning (axis VI: t = 7.93, p < 0.0001; d = .17). When analysing relative differences in the two
groups, essentially the same patterns were found for boys and girls and for children with/without axis I comorbidity.
Conclusions: Self-selection was found to affect the proportions of ADHD, psychosocial adversity and child global
functioning in the cohort. However, the differences from the general population were small. This indicates that
studies on ADHD and multiaxial classifications in MoBa, as well as other cohort studies with similar self-selection
biases, may have reasonable generalisability to the general child population.
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Background
Attention Deficit Hyperactivity Disorder (ADHD) is a
heritable, neurodevelopmental disorder with childhood
onset, characterized by persistence of hyperactivity, im-
pulsivity and attention deficit [1, 2]. The worldwide
prevalence rate of childhood ADHD has been estimated
to 3.40–5.29% in meta-analyses [3, 4]. Estimates indicate
that boys out-represent girls by 2:1 to 9:1 depending on
the ADHD subtype, and the setting, children referred to
Child and Adolescent Mental Health Services (CAMHS)
are more likely to be boys [5]. ADHD constitutes a major
cause behind referral and follow-up in the CAMHS [6–8]
and was the most common child psychiatric diagnosis
(29%) in the Norwegian Patient Registry [8].
In children with ADHD, comorbid disorders are more
common than not; prevalence rates of 67% and 69% were
reported in two large clinical European and American
multisite studies [9, 10]. Comorbid disruptive behaviour
disorders are among the most prevalent in both
population-based and clinical studies [9–17], and approxi-
mately half the children with ADHD have co-existing Op-
positional Defiant Disorder [2]. Learning disabilities are
frequent in a substantial minority, although rates vary
considerably according to the definition used [18, 19].
Two review studies reported mean comorbid learning dis-
abilities of 31% and 45% in children with ADHD, respect-
ively [20, 21]. ADHD has been found to be associated with
reduced psychosocial functioning in children both with
and without learning disabilities [19] and in children with
multiple comorbid psychiatric disorders [9]. Furthermore,
reduced psychosocial functioning in the family was found
to be more pronounced in children with co-occurring dis-
orders [22]. In a European multisite study (n = 1478),
similar rates of psychiatric disorders were found in boys
and girls when assessed by clinicians, although parents de-
scribed more emotional symptoms in girls [23]. The gen-
der distribution of referred children varied considerably in
the included sites, but no significant gender differences
were found in the received treatment, or the time interval
between seeking treatment and ADHD diagnosis.
Population studies are designed to detect genetic- and
environmental causes of disease, and frequently present
findings about ADHD [24–26]. However, participation
rates in population studies are often low [27–29]. When
studying childhood ADHD, there is increased risk of
under-representation, because of a threefold risk of non-
participation by people with mental disorders [30]. One
study found child ADHD to be twice as prevalent among
nonparticipants as among participants [31]. Further-
more, ADHD is a familial disorder [1] associated with
socio-economic disadvantages (i.e., low parental educa-
tional levels and income, single parenthood) [32]. These
psychosocial factors are associated with self-selection and
attrition in longitudinal studies, and selective drop-outs of
participants have been found to lower prevalence-rates
[33]. Consequently, there is uncertainty about the ex-
tent to which participants in population studies are rep-
resentative of children with ADHD in the general
population. Earlier studies have investigated the possible
consequences of nonparticipation using selected exposure-
outcome associations around the time of birth. In spite of
lower prevalence rates, they found no substantial relative
group differences in the selected exposure-outcome asso-
ciations, suggesting that these associations are not biased
by self-selection [27, 34]. However, these studies did
not investigate associations between clinical outcomes
commonly under scrutiny in the ADHD literature: co-
morbidity of psychiatric disorders, learning disabilities,
psychosocial – and global functioning.
The Norwegian Mother and Child Cohort Study (MoBa),
involving about 110 000 children followed from pregnancy
onwards, represents a unique opportunity to investigate
risk factors, developmental trajectories and clinical features
of mental disorders such as ADHD [35]. However, in line
with other population studies [36–38], MoBa participants
have been found to be somewhat better educated than the
rest of the population, with risk groups such as young
mothers and mothers living alone under-represented [34].
The present study reports on data from a nationwide
patient registry using the Multiaxial Classification of
Child and Adolescent Psychiatric Disorders [39, 40] on
children diagnosed with ADHD reported by CAMHS.
The strengths of register studies are that they reflect the
daily clinical work with child disorders diagnosed only
when associated with impairments in need of referral to
CAMHS [10] and the registration of multiaxial classifi-
cations. The multiaxial classifications include six axes
(I–VI) I: Clinical psychiatric disorders, II: Specific disor-
ders of psychosocial development; Learning disabilities,
III: Intellectual disabilities, IV: Medical conditions, V:
The associated abnormal psychosocial situations [41]
and VI: Children’s Global Assessment Scale; CGAS [42],
range 0–100, higher values imply better functioning.
To our knowledge, the present study is the first to use in-
formation from all axes on the Multiaxial Classification of
Child and Adolescent Psychiatric Disorders [40] in children
with ADHD to compare proportions of these classifications
between a large cohort study and the general child popula-
tion. The present study adds to the previous literature by
investigating these broad clinical assessments at a later age,
years after pregnancy.
The aim of the present study was to examine the repre-
sentativeness of child ADHD in the MoBa by using these
multiaxial classifications, as reported to the Norwegian
Patient Registry from CAMHS, to:
1. a. Compare the proportions of ADHD in MoBa and
the general child population,
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b. Compare the proportions of comorbid disorders,
abnormal psychosocial situations and child global
functioning in these two ADHD groups.
2. Investigate the relative differences in multiaxial
classifications for boys and girls and for children
with/without axis I comorbidity, respectively, in
these two ADHD groups.
Based on previous research, we hypothesized that
1. There would be a lower proportion of ADHD in
MoBa than in the general child population, as well
as better psychosocial- and global functioning for
children with ADHD in MoBa; and
2. There would be few relative differences in multiaxial
classifications for boys and girls, and for children with/
without axis I comorbidity in the two ADHD groups.
Methods
Participants
The present study included all Norwegian children born
between January 1, 2000 and December 31, 2008 that
were registered with a diagnosis of ADHD reported by
CAMHS to the National Patient Registry (NPR) between
January 1, 2008 and December 31, 2013. In Norway,
health services use the International Classification of
Diseases, 10th ed. [39], with the diagnosis Hyperkinetic
Disorder (code F90 or F98.8) which corresponds to the
diagnosis ADHD in the Diagnostic and statistical manual
of mental disorders; DSM-5 [2]. We included children in
inpatient- and/or outpatient care in the CAMHS that
had at least one registration of ADHD. Two groups were
defined: 1. Children with ADHD in MoBa and 2. Children
with ADHD in the general child population.
There were 524 726 children born in Norway in the de-
fined time period (269 733 boys and 255 993 girls) [43],
110 230 children of whom were registered as participants
in MoBa (56 533 boys, 53 697 girls). MoBa (https://
www.fhi.no/studier/moba/) is a prospective population-
based cohort study conducted by the Norwegian Institute
of Public Health [35, 44]. Of the 277 702 pregnant women
invited to take part in the study during the 10-year enroll-
ment period, 41% agreed to participate [34, 35, 44].
The Norwegian Patient Registry (NPR) is a national
health-care registry that receives patient-data reported from
all the specialized mental health care services in Norway,
including the CAMHS. According to the Norwegian Health
Register Act and the NPR-regulation passed by the Norwe-
gian parliament in 2007 it is mandatory for the specialized
health-care services to report health-care data to the NPR.
Consequently, individual-level health data are available
from 2008 onward. The personal identification numbers
are stored in encrypted form in the NPR. NPR receives
diagnoses from CAMHS in accordance with the Multiaxial
Classification of Child and Adolescent Psychiatric Disorders
[39], which includes six axes; I: Clinical psychiatric disor-
ders, II: Specific disorders of psychosocial development;
Learning disabilities, III: Intellectual disabilities, IV: Medical
conditions, V: Associated abnormal psychosocial situations,
where every category is coded as present or absent, and an
overall score of the number of different psychosocial adver-
sities can be made [41] and VI: Children’s Global Assess-
ment Scale; CGAS [42]. CGAS is a clinician-rated tool
used in both research and clinical settings to indicate the
lowest overall level of the child’s psychosocial functioning
(at home, at school, with peers). CGAS is divided into 10-
point intervals, with a description of the child’s level of
functioning for each interval. Moderate inter-rater reli-
ability was found when used in a clinical setting with
untrained raters [45].
Measures
For the present study, identification of the MoBa partici-
pants in the NPR was submitted to the co-author
employed at the NPR, through the personal identification
number. The same co-author extracted descriptive NPR
data (see below) and the multiaxial classification data for
children with ADHD in MoBa and in the general popula-
tion. The NPR provided anonymous information from the
registry to the current group of authors.
This information includes descriptive data in the form
of gender, age at first CAMHS-contact and at first ADHD
diagnosis, number of days and contacts in CAMHS and
the multiaxial classification data: Comorbid child psy-
chiatric disorders (axis I), learning- and intellectual
disabilities (axes II and III), epilepsy (axis IV), the asso-
ciated abnormal psychosocial situations (axis V), see
Table 1. Summarized scores were computed for whether
any of the comorbid axes I and II disorders (respectively)
were present at least once. The total number of registered
associated abnormal psychosocial situations comprised a
computed axis V score. The child’s lowest CGAS score at
the time of the ADHD-diagnosis (+/–3 months) = axis VI.
(See Appendix for detailed diagnostic codes used to
compute sum-scores on axes I, II and V).
Statistics
The characteristics of the two groups of children regis-
tered with ADHD in MoBa and the general population
are given as number of participants, proportions (%),
means, and Cohen’s d, as appropriate. The gender distri-
butions were estimated as odds ratios. The two ADHD
groups were compared by using one sample binomial
test for categorical variables, and one sample t-test
(mean) or one sample Wilcoxon (median) for continu-
ous variables, as appropriate, thereby accounting for the
inter-dependency between children with ADHD in the
MoBa and in the general child population.
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We also compared the relative differences in the
multiaxial classifications for boys and girls and for chil-
dren with/without axis I comorbidity, respectively in
these two groups of children with ADHD. For categorical
variables, we used the ratio of relative frequencies where
ratios below 1 indicated under-representation of the char-
acteristic in MoBa, whereas a ratio above 1 indicated
over-representation. For continuous variables, we used
a one-sample t-test, and Cohen’s d expressed the mag-
nitude and direction of differences. (Because of a low
number of registrations, we could not analyse data from
axis IV when investigating the relative differences).
Results
Among the 524 726 Norwegian children born between
January 1, 2000 and December 31, 2008, a total of 11
119 children (2.11%) were registered in the NPR with an
ADHD diagnosis between January 1, 2008 and Decem-
ber 31, 2013, significantly more than among children in
the MoBa, where 1.45% (1595/110 230) were registered
with ADHD (p < 0.0001).
Boys had higher odds ratio (OR) for having ADHD
than girls (OR = 2.79, p < 0.001) in the general child
population, and in the MoBa (OR = 2.78, p < 0.001).
The MoBa participants were approximately 0.6 years
younger at first contact with CAMHS, and 0.5 years youn-
ger when first registered with an ADHD diagnosis com-
pared with the general child population (p < 0.0001).
Table 1 presents ADHD group comparisons using
mean sum scores for axes I, II, and V, while the Appen-
dix presents more detailed diagnostic data used to com-
pute these sum scores.
Comorbid psychiatric disorders and learning disabilities
were found in approximately 30% and 20%, respectively of
children with ADHD in both MoBa and the general child
population. There were no significant group differences
regarding intellectual disabilities (axis III) or epilepsy
(axis IV). Abnormal psychosocial situations registered
on axis V were significantly less frequent in children
with ADHD in MoBa compared to children with ADHD in
the general child population, and child global functioning
was significantly better in MoBa, with effect sizes < .30 (see
Table 1). See Appendix for a detailed overview of the single
international classification codes for axes I, II and V.
Tables 2 and 3 present the relative differences in
multiaxial classifications for boys and girls and for chil-
dren with/without axis I comorbidity, respectively, in the
two ADHD groups. These results were essentially the
same as those previously presented for all children with
ADHD in MoBa and the general child population
(Table 1); fewer abnormal psychosocial situations (axis
V), and better child global functioning (axis VI) in MoBa
participants, with effect sizes < .26.
Discussion
The present study addressed the representativeness of reg-
istered ADHD in a large population- based cohort study.
We know of no other studies that have investigated repre-
sentativeness by comparing clinically registered ADHD
and multiaxial classifications in a cohort with those in the
general population. However, previous studies have esti-
mated bias due to nonparticipation [27, 34] and loss to
follow-up [28] using pre- and perinatal exposures and a
variety of outcomes. The biases in these studies were
interpreted as modest for the investigated medical factors.
In a MoBa study of NPR registered Autism Spectrum Dis-
orders, self-selection bias was investigated by comparing
selected pre- and perinatal exposures to Autism Spectrum
Table 1 NPR-descriptives and multiaxial classifications in children with ADHD in MoBa (n = 1595) and the general child population;
All (n = 11 119)
NPR-descriptives Mean (sd) MoBa Mean (sd) All Statistics
Age (years) at first contact in CAMHS 7.07 (1.84) 7.64 (1.97) t = -12.3, df = 1594, p < 0.0001, d = -.30(a)
Age (years) at first ADHD diagnosis in CAMHS 7.87 (1.76) 8.38 (1.96) t = -.11.5, df =1594, p < 0.0001, d = -.27(a)
Number of days in CAMHS 858 (566) 949 (604) p = 0.85(b)
Number of contacts in CAMHS 38 (40) 44 (51) p = 0.03, d = -.13(b)
Multiaxial classifications % MoBa % All
Axis I, psychiatric disorders 29.5% 29.5% z = 0, p = 1.0(c)
Axis II, learning disabilities 19.3% 20.4% z = 1.09, p = 0.28(c)
Axis III, intellectual disabilities (F70–F79) 1.3% 1.8% z = 1.50, p = 0.13(c)
Axis IV, epilepsy (G40) 1.3% 1.3% z = 0, p = 1.0(c)
Mean (sd) MoBa Mean (sd) All
Axis V, abnormal psychosocial situations (sum-score) 0.64 (0.89) 0.81 (1.01) t = 7.63, p < 0.001, d = -.18(a)
Axis VI, CGAS 55.0 (13.1) 52.4 (17.19 t = 7.93, p < 0.001, d = .17(a)
NPR Norwegian patient registry, MoBa the Norwegian Mother and Child Cohort Study, CAMHS Child and Adolescent Mental Health Clinics, CGAS Children’s Global
Assessment Scale. (a) One sample t-test (b) Wilcoxon (c) Binominal test for categorical variables
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Disorders in the cohort and the general child population
[46]. Despite the under- and over-representation of several
exposures in the cohort, all effect estimates of exposure-
outcome associations deviated less than 16% from those
estimated in the population. The authors concluded that
self-selection did not appear to compromise validity of
exposure-outcome associations in the study of Autism
Spectrum Disorders in MoBa [46].
Despite differences in methodology between our study
and the previous ones, our results are consistent with
the overall pattern in these studies, as we found small
differences in the multiaxial classifications between chil-
dren with ADHD in the cohort and children with
ADHD in the general population. This indicates that the
findings within the MoBa-population may be generalis-
able on these terms.
Table 2 Comparing relative differences for boys and girls in the multiaxial classifications in the two groups of children with ADHD;
MoBa and the general child population (All)
MoBa All Statistics
N(1) (%) N(2) (%) Ratio of relative frequencies
(95% CI), p, d
With axis I comorbidity
-girls 100 (24.4) 701 (24.5) 1.00 (0.84–1.20), p = 0.98
-boys 370 (31.2) 2576 (31.2) 1.01 (0.92–1.10), p = 0.88
With axis II comorbidity
-girls 81 (19.8) 562 (19.6) 1.01 (0.82–1.25), p = 0.91
-boys 227 (19.2) 1704 (20.6) 0.93 (0.82–1.06), p = 0.28
With axis III comorbidity
-girls 3 (0.7) 55 (1.9) 0.38 (0.12–1.22), p = 0.10
-boys 18 (1.5) 140 (1.7) 0.90 (0.55–1.47), p = 0.68
Axis V scores Mean (SD) Mean (SD)
-girls 0.56 (0.79) 0.79 (0.98) t = 4.55, p < 0.0001, d = -.26
-boys 0.66 (0.92) 0.82 (1.02) t = 5.11, p < 0.0001, d = -.21
Axis VI scores
-girls 55.8 (13.2) 54.2 (16.6) t = -1.87, p = 0.06, d = .11
-boys 54.7 (12.9) 51.7 (17.3) t = -5.75, p < 0.0001, d = .20
1MoBa; the Norwegian Mother and Child Cohort Study: Total number of girls = 410, and boys = 1185, 2All: Total number of girls = 2865, and boys = 8254
Table 3 Comparing relative differences for children with and without axis I comorbidity in the multiaxial classifications in the two
groups in the two groups of children with ADHD; MoBa and the general child population (All)
MoBa All Statistics
N (a) (%) N (b) (%) Ratio of relative frequencies
(95% CI) p, d
With axis II comorbidity
-with axis I comorbididity 104 (22.1) 666 (20.3) 1.09 (0.91–1.31), p = 0.36
-without axis I comorbidity 204 (18.1) 1600 (20.4) 0.89 (0.78–1.01), p = 0.08
With axis III comorbidity
-with axis I comorbidity 470 (2.1) 3277 (2.4) 0.88 (0.46–1.69), p = 0.71
-without axis I comorbidity 11 (1.0) 116 (1.5) 0.66 (0.36–1.22), p = 0.19
Axis V scores Mean (SD) Mean (SD)
-with axis I comorbidity .94 (1.1) 1.17 (1.21) t = 3.89, p = 0.0001, d = -.20
-without axix I comorbidity .51 (.75) .66 (.88) t = 5.44, p < 0.0001, d = -.18
Axis VI scores
-with axis I comorbidity 51.0 (15.3) 48.2 (18.3) t = -3.16, p = 0.002, d = .17
-without axis I comorbidity 56.7 (11.7) 54.2 (16.2) t = -4.99, p < 0.0001, d = .18
MoBa the Norwegian Mother and Child Cohort Study; aMoBa: Total number with axis I-comorbidity = 470, without = 1125, bAll: Total number with axis I-comorbidity =3277,
without = 7842
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The overall 2.11% of Norwegian children registered
with ADHD is relatively similar to prevalence findings
from other Nordic countries [47]. Earlier studies have
shown that the variability in ADHD prevalence estimates
was mostly explained by methodological characteristics
of the studies [3]. The requirement of impairment, and
the use of clinicians as informants lower these estimates
[4, 48, 49]. In the present study, we may assume that the
children were impaired as they were patients in the
CAMHS. As hypothesized, we found a significantly
lower proportion of ADHD diagnoses in the cohort
(1.45%) than in the general child population (2.11%),
suggesting self-selection, in line with other population
studies reporting significantly fewer children with both
ADHD [50] and Autism Spectrum Disorders [46] among
study participants compared to nonparticipants.
The proportion of comorbid psychiatric disorders (axis I)
found in the present study (30%) was lower than the 52%
[10] and 76.7% [17] reported in two Nordic cohort studies.
There is no obvious explanation for the lower proportions
in the present study, but one contributing factor could be
the wider age range in the other Nordic studies, which in-
cluded children up to 17 years [10] and 20 years [17] com-
pared with our upper age limit of 13 years. We may
speculate whether the lower proportions of comorbid psy-
chiatric disorders also reflect an under-reporting of clinic-
ally significant comorbidity from the clinicians to the
patient registries [51]. Presumably, clinicians may be prone
to registering the most impairing diagnosis only, as is often
found in studies from CAMHS [52–54]. However, the over-
all similar proportions of comorbid axes I–III classifications
(psychiatric disorders, learning- and intellectual disabilities)
in MoBa and the general child population strengthen the
representativeness of MoBa, as the registry data was in-
dependently collected and available for both groups of
children with ADHD.
As hypothesized, we found fewer abnormal psycho-
social situations (axis V) in children with ADHD in
MoBa than in the general child population. This is in ac-
cordance with studies reporting that the frequency of
clinical ADHD is elevated in socio-economically disad-
vantaged groups [55, 56] with more family problems [57,
58] and that socio-economic disadvantages may be a
barrier to participation in studies [29, 30]. The better
child global functioning (axis VI, CGAS) in MoBa-
participants is consistent with an adult study, reporting
less functional impairment in study participants than in
a community sample [59]. Both ADHD-groups in the
present study had mean CGAS scores indicating mode-
rate child global impairment (52.4 and 55), similar to
that of the clinical, multisite ADORE study on children
with ADHD (n = 14 825), which reported a mean CGAS
of 55 [60]. However, the slightly better CGAS in children
with ADHD in MoBa (Table 1) could be partly explained
by these children having fewer consultations in CAMHS
(Table 1).
That children with ADHD in MoBa were significantly
younger at first contact with CAMHS (and when first regis-
tered with ADHD) could be related to their better-educated
parents seeking help at an early age [34]. We consider this
to be one possible explanation, as received treatment has
been found to be associated with higher socio-economic
status, despite Norway being a highly egalitarian country,
with a free, universal health-care system [61].
Earlier studies on the representativeness of cohort studies
quantified bias by also comparing relative ratios (within
group associations) using registry data available for both
the cohorts and the general child populations [28, 46]. As
this method has been regarded as a direct measure of gen-
eralisability of cohort study results [28, 46], we used a cor-
responding method by investigating the relative differences
in multiaxial classifications within the two groups of chil-
dren with ADHD. Inspection of crude numbers and
effect sizes of the relative differences for boys and
girls and for children with/without axis I comorbidity
(Tables 2 and 3), show that they are essentially the
same as those found for all children with ADHD in
MoBa and the general child population (Table 1),
thereby supporting the generalisability of our findings.
Strengths and limitations
A strength of the present study is the use of the a na-
tional patient registry which as far as all data are re-
ported as obliged, includes all patients treated within
CAMHS in Norway and provides valuable information
about ADHD in CAMHS and may be considered repre-
sentative of clinical practice.
Our study had several limitations. First, we only included
data reported to the NPR as registered by clinicians in
CAMHS, thus not children diagnosed only within primary
care. Second, low rates of comorbid disorders in children
with ADHD may have resulted in underestimated group
differences. Third, we had a follow-up period of six years
and only children up until age 13 years were included.
Finally, we do not know the reliability and validity of
the clinically registered diagnoses.
Conclusions
Self-selection was found to affect the proportions of
ADHD, psychosocial adversity and child global func-
tioning in the cohort. However, the differences from
the general population were small. This supports that
studies on ADHD and multiaxial classifications in
MoBa, as well as in other cohort studies with similar
self-selection biases, may have reasonable generalisability
to the general child population.
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Tics (F95) 8.5 7.5 z = 0.52, p = 0.13
Elimination disorders (F98) 3.1 2.6 z = 0.42, p = 0.21
Axis II, learning disabilities
Specific disorders of speech and language (F80) 7.8 7.4 z = 0.61, p = 0.54
Specific disorder of scholastic skills (F81) 8.6 10.4 z = 2.36, p = 0.02
Specific disorder of motor function (F82) 2.8 2.1 z = 1.95, p = 0.05
Mixed specific developmental disorders (F83) ≥ 2 F80-F82) 2.4 2.4 z = 0, p = 1
Axis V, associated abnormal psychosocial situations % MoBa % All
1 Abnormal intrafamilial relationships 6.6 8.7 z = 2.98, p = 0.003
2 Mental disorder, deviance or handicap in the child’s primary support group 14.4 17.0 z = 2.76, p = 0.005
3 Inadequate or distorted intrafamilial communication 2.4 3.1 z = 1.61, p = 0.11
4 Abnormal qualities of upbringing 2.6 3.3 z = 0.57, p = 0.12
5 Abnormal immediate environment 23.1 29 z = 5.19, p < 0.001
6 Acute life events 4.4 7.1 z = 4.20, p < 0.001
7 Societal stressors 0.8 2 z = 3.42, p = 0.006
8 Chronic interpersonal stress associated with school/work 4.1 5.1 z = 1.82, p = 0.07
9 Stressful events/situations resulting from the child’s own disorder/disability 5.1 5.8 z = 1.20, p = 0.23
NPR Norwegian Patient Registry; MoBa The Norwegian Mother and Child Cohort Study
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